# Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match

> **NCT01500161** · PHASE2 · TERMINATED · sponsor: **Texas Oncology Cancer Center** · enrollment: 1 (actual)

## Conditions studied

- Acute Myelogenous Leukemia
- Acute Lymphocytic Leukemia
- Chronic Lymphocytic Leukemia
- Chronic Myelogenous Leukemia
- Hodgkins Disease
- Non-Hodgkins Lymphoma
- Aplastic Anemia
- Multiple Myeloma
- Myelodysplastic Syndrome

## Interventions

- **DRUG:** Busulfan
- **DRUG:** Clofarabine
- **DRUG:** Fludarabine
- **DRUG:** Melphalan
- **DRUG:** Carmustine
- **DRUG:** Etoposide
- **DRUG:** Cytarabine

## Key facts

- **NCT ID:** NCT01500161
- **Lead sponsor:** Texas Oncology Cancer Center
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-11
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Insufficient accruals
- **Last updated:** 2013-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01500161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01500161, "Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01500161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*